The University of Chicago Header Logo

Connection

Deric Park to Female

Back to Details
This is a "connection" page, showing publications Deric Park has written about Female.
Deric Park
Connection Strength
0.264
Female
  1. Efficient ADCC killing of meningioma by avelumab and a high-affinity natural killer cell line, haNK. JCI Insight. 2019 10 17; 4(20).
    View in: PubMed
    Score: 0.032
  2. Protein phosphatase 2A inhibition enhances radiation sensitivity and reduces tumor growth in chordoma. Neuro Oncol. 2018 05 18; 20(6):799-809.
    View in: PubMed
    Score: 0.029
  3. LB-100, a novel Protein Phosphatase 2A (PP2A) inhibitor, sensitizes malignant meningioma cells to the therapeutic effects of radiation. Cancer Lett. 2018 02 28; 415:217-226.
    View in: PubMed
    Score: 0.028
  4. Phase I study of RO4929097 with bevacizumab in patients with recurrent malignant glioma. J Neurooncol. 2016 12; 130(3):571-579.
    View in: PubMed
    Score: 0.026
  5. Combined PDGFR and HDAC Inhibition Overcomes PTEN Disruption in Chordoma. PLoS One. 2015; 10(8):e0134426.
    View in: PubMed
    Score: 0.024
  6. Multiple discrete aneurysmal subarachnoid hemorrhages during multimodality management of a hypothalamic glioma--case report. Clin Neurol Neurosurg. 2013 May; 115(5):632-5.
    View in: PubMed
    Score: 0.019
  7. Chordoma model. J Neurosurg. 2012 Apr; 116(4):799-800; discussion 800.
    View in: PubMed
    Score: 0.019
  8. Identifying Muir-Torre syndrome in a patient with glioblastoma multiforme. Neuro Oncol. 2009 Aug; 11(4):452-5.
    View in: PubMed
    Score: 0.015
  9. von Hippel-Lindau disease-associated hemangioblastomas are derived from embryologic multipotent cells. PLoS Med. 2007 Feb; 4(2):e60.
    View in: PubMed
    Score: 0.013
  10. Pharmacotherapy of primary CNS lymphoma. Expert Opin Pharmacother. 2002 Jan; 3(1):39-49.
    View in: PubMed
    Score: 0.009
  11. Asymptomatic brainstem lesions and pachymeningeal enhancement after anti-PD-1 therapy. Immunotherapy. 2021 01; 13(1):11-17.
    View in: PubMed
    Score: 0.009
  12. Combination of PARP inhibitor and temozolomide to suppress chordoma progression. J Mol Med (Berl). 2019 08; 97(8):1183-1193.
    View in: PubMed
    Score: 0.008
  13. Dexamethasone-induced immunosuppression: mechanisms and implications for immunotherapy. J Immunother Cancer. 2018 06 11; 6(1):51.
    View in: PubMed
    Score: 0.007
  14. Enhancement of mitochondrial biogenesis and paradoxical inhibition of lactate dehydrogenase mediated by 14-3-3? in oncocytomas. J Pathol. 2018 07; 245(3):361-372.
    View in: PubMed
    Score: 0.007
  15. Clinical decision making in the era of immunotherapy for high grade-glioma: report of four cases. BMC Cancer. 2018 03 01; 18(1):239.
    View in: PubMed
    Score: 0.007
  16. Bevacizumab used for the treatment of severe, refractory perilesional edema due to an arteriovenous malformation treated with stereotactic radiosurgery. J Neurosurg. 2012 May; 116(5):972-7.
    View in: PubMed
    Score: 0.005
  17. Proteomic profiling of von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 pheochromocytomas reveals different expression of chromogranin B. Endocr Relat Cancer. 2007 Jun; 14(2):463-71.
    View in: PubMed
    Score: 0.003
  18. HLA-DRB5*0101 and -DRB1*1501 expression in the multiple sclerosis-associated HLA-DR15 haplotype. J Neuroimmunol. 2005 Oct; 167(1-2):108-19.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.